Kilitch Drugs (India) Limited, is entering the Rs 600 crore eye care market with the launch of its new company — Eyekare Kilitch Ltd.
HT Image
Kilitch Drugs (India) Ltd, will initially hold 100 per cent capital, with the equity capital being Rs 20 crore as a project advance. The industry estimates an annual growth rate of 12 per cent for the eye care products market. Mukund Mehta, MD of Kilitch Drugs (India), said, Eyekare Kilitch will launch 15 eye care products in the first year.